Arine Secures $29 Million To Meet High Demand For Its Medication Intelligence Platform
08/17/22, 10:46 AM
Location
san franciscoMoney raised
$29 million
Industry
information technology
Arine, a next-generation medication intelligence company, today announced that it has raised $29 million in Series B funding composed of equity and debt financing. The round was led by 111° West Capital, with participation from new investors MBX Capital and New Leaf Venture Partners and continued support from Katalyst Ventures and Super Capital Group.
Company Info
Location
595 market st.
san francisco, california, united states
Additional Info
Arine’s industry-leading software platform seamlessly integrates cutting-edge AI, clinical expertise, and advanced data analytics to deliver medication-based care interventions at the population level. Using Arine outcomes data, these proactive interventions are dynamically updated to provide a value-based solution that improves patient outcomes and reduces costs with unparalleled precision and efficiency.